Literature DB >> 32284320

Francisella novicida CRISPR-Cas Systems Can Functionally Complement Each Other in DNA Defense while Providing Target Flexibility.

Hannah K Ratner1,2,3, David S Weiss4,3,5.   

Abstract

CRISPR-Cas systems are prokaryotic adaptive immune systems that facilitate protection of bacteria and archaea against infection by external mobile genetic elements. The model pathogen Francisella novicida encodes a CRISPR-Cas12a (FnoCas12a) system and a CRISPR-Cas9 (FnoCas9) system, the latter of which has an additional and noncanonical function in bacterial virulence. Here, we investigated and compared the functional roles of the FnoCas12a and FnoCas9 systems in transformation inhibition and bacterial virulence. Unlike FnoCas9, FnoCas12a was not required for F. novicida virulence. However, both systems were highly effective at plasmid restriction and acted independently of each other. We further identified a critical protospacer-adjacent motif (PAM) necessary for transformation inhibition by FnoCas12a, demonstrating a greater flexibility for target identification by FnoCas12a than previously appreciated and a specificity that is distinct from that of FnoCas9. The effectors of the two systems exhibited different patterns of expression at the mRNA level, suggesting that they may confer distinct benefits to the bacterium in diverse environments. These data suggest that due to the differences between the two CRISPR-Cas systems, together they may provide F. novicida with a more comprehensive defense against foreign nucleic acids. Finally, we demonstrated that the FnoCas12a and FnoCas9 machineries could be simultaneously engineered to restrict the same nonnative target, thereby expanding the toolset for prokaryotic genome manipulation.IMPORTANCE CRISPR-Cas9 and CRISPR-Cas12a systems have been widely commandeered for genome engineering. However, they originate in prokaryotes, where they function as adaptive immune systems. The details of this activity and relationship between these systems within native host organisms have been minimally explored. The human pathogen Francisella novicida contains both of these systems, with the Cas9 system also exhibiting a second activity, modulating virulence through transcriptional regulation. We compared and contrasted the ability of these two systems to control virulence and restrict DNA within their native host bacterium, highlighting differences and similarities in these two functions. Collectively, our results indicate that these two distinct and reprogrammable endogenous systems provide F. novicida with a more comprehensive defense against mobile genetic elements.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  CRISPR-Cas; Cas12a; Cas9; Cpf1; DNA targeting; Francisellazzm321990; pathogenesis; plasmid restriction

Year:  2020        PMID: 32284320      PMCID: PMC7253609          DOI: 10.1128/JB.00670-19

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  64 in total

1.  Identification of genes that are associated with DNA repeats in prokaryotes.

Authors:  Ruud Jansen; Jan D A van Embden; Wim Gaastra; Leo M Schouls
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

Review 2.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

3.  In vivo negative selection screen identifies genes required for Francisella virulence.

Authors:  David S Weiss; Anna Brotcke; Thomas Henry; Jeffrey J Margolis; Kaman Chan; Denise M Monack
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

Review 4.  I can see CRISPR now, even when phage are gone: a view on alternative CRISPR-Cas functions from the prokaryotic envelope.

Authors:  Hannah K Ratner; Timothy R Sampson; David S Weiss
Journal:  Curr Opin Infect Dis       Date:  2015-06       Impact factor: 4.915

5.  Catalytically Active Cas9 Mediates Transcriptional Interference to Facilitate Bacterial Virulence.

Authors:  Hannah K Ratner; Andrés Escalera-Maurer; Anaïs Le Rhun; Siddharth Jaggavarapu; Jessie E Wozniak; Emily K Crispell; Emmanuelle Charpentier; David S Weiss
Journal:  Mol Cell       Date:  2019-06-27       Impact factor: 17.970

6.  Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin.

Authors:  Alexander Bolotin; Benoit Quinquis; Alexei Sorokin; S Dusko Ehrlich
Journal:  Microbiology       Date:  2005-08       Impact factor: 2.777

7.  Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.

Authors:  Robert J Citorik; Mark Mimee; Timothy K Lu
Journal:  Nat Biotechnol       Date:  2014-09-21       Impact factor: 54.908

8.  Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression.

Authors:  Michelle L Luo; Adam S Mullis; Ryan T Leenay; Chase L Beisel
Journal:  Nucleic Acids Res       Date:  2014-10-17       Impact factor: 16.971

9.  Cas9-mediated targeting of viral RNA in eukaryotic cells.

Authors:  Aryn A Price; Timothy R Sampson; Hannah K Ratner; Arash Grakoui; David S Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

10.  The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.

Authors:  Krzysztof Chylinski; Anaïs Le Rhun; Emmanuelle Charpentier
Journal:  RNA Biol       Date:  2013-04-05       Impact factor: 4.652

View more
  2 in total

1.  crRNA complementarity shifts endogenous CRISPR-Cas systems between transcriptional repression and DNA defense.

Authors:  Hannah K Ratner; David S Weiss
Journal:  RNA Biol       Date:  2021-03-18       Impact factor: 4.652

Review 2.  Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine.

Authors:  Matthew W McCarthy
Journal:  Expert Rev Anti Infect Ther       Date:  2020-05-04       Impact factor: 5.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.